Zenarestat - Astellas Pharma
Alternative Names: FK-366; FR-74366Latest Information Update: 29 Aug 2009
At a glance
- Originator Astellas Pharma
- Developer Astellas Pharma; Pfizer
- Class Acetic acids; Antihyperglycaemics; Bromobenzenes; Chlorinated hydrocarbons; Fluorobenzenes; Quinazolines; Small molecules
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic neuropathies; Diabetic retinopathy